Hongzhou Cai

1.4k total citations
44 papers, 1.0k citations indexed

About

Hongzhou Cai is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Hongzhou Cai has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 16 papers in Cancer Research and 13 papers in Surgery. Recurrent topics in Hongzhou Cai's work include Bladder and Urothelial Cancer Treatments (11 papers), Epigenetics and DNA Methylation (7 papers) and MicroRNA in disease regulation (5 papers). Hongzhou Cai is often cited by papers focused on Bladder and Urothelial Cancer Treatments (11 papers), Epigenetics and DNA Methylation (7 papers) and MicroRNA in disease regulation (5 papers). Hongzhou Cai collaborates with scholars based in China, Italy and United States. Hongzhou Cai's co-authors include Ting Xu, Zicheng Xu, Xinwei Wang, Qing Zou, Changjun Yin, Qiang Cao, Xiaobing Ju, Bin Yu, Chao Qin and Pengfei Shao and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and Clinical Cancer Research.

In The Last Decade

Hongzhou Cai

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongzhou Cai China	18	610	493	235	203	149	44	1.0k
Babak Yazdani‐Biuki Austria	17	483 0.8×	288 0.6×	155 0.7×	292 1.4×	151 1.0×	26	950
Naseem J. Zojwalla United States	15	429 0.7×	481 1.0×	275 1.2×	404 2.0×	101 0.7×	26	948
Guoqing Liao China	18	511 0.8×	237 0.5×	502 2.1×	316 1.6×	110 0.7×	56	1.2k
Samanta Salvi Italy	18	442 0.7×	551 1.1×	491 2.1×	300 1.5×	91 0.6×	45	1.0k
Pierre‐Alexandre Just France	17	415 0.7×	222 0.5×	281 1.2×	269 1.3×	50 0.3×	45	1.1k
Pinkal Desai United States	17	398 0.7×	371 0.8×	129 0.5×	198 1.0×	64 0.4×	71	1.2k
Jie Ding China	16	604 1.0×	160 0.3×	178 0.8×	205 1.0×	105 0.7×	57	1.2k
Shripad Sinari United States	13	407 0.7×	210 0.4×	150 0.6×	216 1.1×	43 0.3×	22	891
R. Nam Canada	15	460 0.8×	327 0.7×	777 3.3×	264 1.3×	164 1.1×	22	1.2k
Philip M. Spanheimer United States	18	307 0.5×	275 0.6×	159 0.7×	390 1.9×	91 0.6×	63	865

Countries citing papers authored by Hongzhou Cai

Since Specialization

Citations

This map shows the geographic impact of Hongzhou Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongzhou Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongzhou Cai more than expected).

Fields of papers citing papers by Hongzhou Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongzhou Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongzhou Cai. The network helps show where Hongzhou Cai may publish in the future.

Co-authorship network of co-authors of Hongzhou Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Hongzhou Cai. A scholar is included among the top collaborators of Hongzhou Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongzhou Cai. Hongzhou Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Tang, Haifei Xu, Yuhao Lu, et al.. (2024). Advances in tumor microenvironment and underlying molecular mechanisms of bladder cancer: a systematic review. Discover Oncology. 15(1). 111–111. 4 indexed citations

Qi, Feng, et al.. (2024). Metabolic Reprogramming of Cancer‐Associated Fibroblasts: Transforming Tumor Accomplices into Immunotherapeutic Allies. Advanced Functional Materials. 35(13). 5 indexed citations

Liu, Xinyang, et al.. (2024). Artificial intelligence application in the diagnosis and treatment of bladder cancer: advance, challenges, and opportunities. Frontiers in Oncology. 14. 1487676–1487676. 9 indexed citations

Huang, Xiaochen, Tingting Yang, Dawei Ma, et al.. (2024). Distinct clinical features of urothelial carcinoma with low-expressing human epidermal growth factor receptor 2 status. Translational Andrology and Urology. 13(11). 2419–2429.

Chen, Qiuyang, et al.. (2024). The potential of organoids in renal cell carcinoma research. BMC Urology. 24(1). 120–120. 3 indexed citations

Cao, Yang, et al.. (2024). Perfusion drugs for non‑muscle invasive bladder cancer (Review). Oncology Letters. 27(6). 267–267. 1 indexed citations

Sun, Guangshun, Yuliang Wang, Hanyuan Liu, et al.. (2023). CHSY1 promotes CD8+ T cell exhaustion through activation of succinate metabolism pathway leading to colorectal cancer liver metastasis based on CRISPR/Cas9 screening. Journal of Experimental & Clinical Cancer Research. 42(1). 248–248. 35 indexed citations

Li, Yan, Fenglin Huang, Hongzhou Cai, et al.. (2023). Immunotherapy: Review of the Existing Evidence and Challenges in Breast Cancer. Cancers. 15(3). 563–563. 6 indexed citations

Li, Zhouxiao, et al.. (2023). Extracellular RNA in melanoma: Advances, challenges, and opportunities. Frontiers in Cell and Developmental Biology. 11. 6 indexed citations

10.

Chen, Zhiqiang, Hanyuan Liu, Hongfei Zhu, et al.. (2023). From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era. Biomedicine & Pharmacotherapy. 158. 114208–114208. 17 indexed citations

11.

Cai, Hongzhou, Hongcheng Lu, Weizhang Xu, et al.. (2022). LncRNA SNHG1 Facilitates Tumor Proliferation and Represses Apoptosis by Regulating PPARγ Ubiquitination in Bladder Cancer. Cancers. 14(19). 4740–4740. 13 indexed citations

12.

Lu, Hongcheng, et al.. (2022). Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer. Frontiers in Immunology. 13. 803355–803355. 55 indexed citations

13.

Li, Xiao, Ran You, Xinwei Wang, et al.. (2016). Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review. Clinical Cancer Research. 22(15). 3971–3981. 137 indexed citations

14.

Cai, Hongzhou, Xingjiang Li, Ting Xu, et al.. (2016). ERCC1 C118T polymorphism has predictive value for platinum-based chemotherapy in patients with late-stage bladder cancer. Genetics and Molecular Research. 15(2). 13 indexed citations

15.

Yu, Bin, et al.. (2015). Expressions of stem cell transcription factors Nanog and Oct4 in renal cell carcinoma tissues and clinical significance. Artificial Cells Nanomedicine and Biotechnology. 44(8). 1818–1823. 19 indexed citations

16.

Zhang, Chao, Qiang Cao, Chao Qin, et al.. (2014). Association of erythropoietin gene rs576236 polymorphism and risk of adrenal tumors in a Chinese population. Journal of Biomedical Research. 28(6). 456–456. 7 indexed citations

17.

Yang, Xiao, Pengchao Li, Chao Qin, et al.. (2013). TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population. International Journal of Genomics. 2013. 1–9. 2 indexed citations

18.

Chen, Jiawei, Xinhai Cui, Hai Zhou, et al.. (2013). Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study. BMC Cancer. 13(1). 356–356. 22 indexed citations

19.

Zhu, Chen, Pengfei Shao, Meiling Bao, et al.. (2013). miR-154 inhibits prostate cancer cell proliferation by targeting CCND2. Urologic Oncology Seminars and Original Investigations. 32(1). 31.e9–31.e16. 51 indexed citations

20.

Chen, Jiawei, Pengfei Shao, Qiang Cao, et al.. (2012). Genetic Variations in a PTEN/AKT/mTOR Axis and Prostate Cancer Risk in a Chinese Population. PLoS ONE. 7(7). e40817–e40817. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact